PetLife Pharmaceuticals Retains Invicto Group as their

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
PetLife Pharmaceuticals Retains Invicto Group as their Investor Relations Firm

HANCOOK, Md., July 19, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTCQB:PTLF), a developer of new generation of high potency  veterinary cancer medications  and nutraceuticals for pets, today announces it has retained Invicto Group, a leading investors relations and strategic advisory firm.

Dr. Ralph T. Salvagno, CEO of Petlife Pharmaceuticals noted, “Petlife is poised to change the paradigm of treatment in veterinary oncology. It is reported that over 50% of dogs and cats living past the age of 10 develop cancer meaning that approximately 13 million families yearly have to face this diagnosis in their beloved companion animals. Our all natural Escozine for Pets™ has a strong scientific basis for the treatment of cancer and offers an alternative to standard chemotherapy, surgery and other invasive treatment that are often as toxic as the cancer itself. Petlife’s mission is to provide an affordable solution that also avoids the unfortunate and often deadly side effects of traditional treatment. We hope to soon announce our Investigational New Drug Application seeking FDA approval for our technology and will also work to develop a daily nutraceutical preventive formulation.  We are excited to be working with Invicto Group to assist in our efforts to bring this breakthrough drug to market.”

“After completing our due diligence of the company and its products we look forward to introducing PetLife Pharmaceuticals to the financial and investment community. In addition, we will look to reach out to the over 92 million pet owners in the U.S. and millions more around the world,” said Invicto Group.

About PetLife Pharmaceuticals, Inc.

PetLife Pharmaceuticals (OTCQB:PTLF) ( www.PetLifePharma.com ) is a registered US Veterinary Pharmaceutical company, incorporated in 2012.

PetLife has developed and is launching a new generation of high potency veterinary cancer medications and nutraceuticals for companion pets -- Escozine for Pets™. It is based on the same patented 'Escozine for Humans' formula that has been sold by affiliated companies worldwide in 40 countries.  Escozine for Pets™ uses a patented polarization technology that potentiates the main ingredients to dramatically increase their effectiveness.

PetLife's mission is to bring its new, scientifically proven, non-toxic, potentiated bioactive nutraceuticals and prescription medication to the world of veterinary oncology -- with the ultimate goal of preventing cancer and extending the life of pets suffering from cancer while improving their quality of life. In the US alone, consumer spending on domestic companion animals reached over $60 billion in 2015 with over $29 billion spent on veterinary care and medications.

About Invicto Group

The Invicto Group team brings decades of collective experience, a vast range of expertise to provide investor relations, financial marketing, and advisory services to help public companies in the small-cap and micro-cap market to increase investor awareness and bring value to shareholders.  There are many small-cap and micro-cap companies with top management and high growth potential that have difficulty in conveying their unique opportunity to the right Investors. In a profession that is increasingly complex and regulated, our approach is grounded in purpose and professionalism, backed by thinking that is fresh and creative.

Safe Harbor

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: PetLife encourages those interested in our Company to rely only on information included in our filings with the United States Securities and Exchange Commission which can be found at www.sec.gov . Statements released by the Company, that are not purely historical are forward-looking within the meaning of the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding the company's expectations, hopes, intentions, and strategies for the future. Investors are cautioned that forward-looking statements involve risk and uncertainties that may affect the Company's business prospects and performance. The Company's actual results could differ materially from those in such forward-looking statements. Risk factors include but are not limited to general economic, competitive, governmental, and technological factors as discussed in the Company's filings with the SEC on Forms 10-K, 10-Q, and 8-K. The Company does not undertake any responsibility to update the forward-looking statements contained in this release.

Investor Relations: Invicto Group info@invictogroup.com 800-928-7462 Ext. 801

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Katahdin's Portland Branch Bet Moves Downtown in 2027

Updated Category News Views 61

Exchange Street is getting a real-world vote of confidence, and that is more interesting than another app update ever will be. Katahdin Trust intends to open a full-service branch at 120 Exchange Street in downtown Portland, with renovations slated to begin early in 2027 and an opening expected later that year. For a Maine community bank with nearly $1.2 billion in...

Continue Reading
Washington-to-Asia Advisory Deal Targets Policy Risk

Updated Category News Views 10

Policy bottlenecks are becoming a cost center across Southeast Asia. That is the plain-English backdrop for the strategic partnership announced November 18, 2026, by Beacon Global Strategies and Vriens & Partners. Neither firm is selling a factory, a chip design, or a new energy project. They are selling something companies increasingly cannot afford to improvise: a...

Continue Reading
APEC's Shared-Prosperity Message Needs More Detail

Updated Category News Views 20

Geese make handsome symbols, but markets cannot underwrite a metaphor. The Nov. 18, 2026 report from Xinhua News Agency looks back to remarks Chinese President Xi Jinping made 12 years ago, when he used swan geese to urge APEC economies toward greater cooperation and a new collective flight. Its present-day message is plainly hopeful: the APEC family is moving across the...

Continue Reading
CVRx Lawsuit Deadline Follows a Brutal 59.76% Plunge

Updated Category News Views 24

A 59.76% one-day wipeout has a way of stripping the varnish off every upbeat corporate story. For CVRx investors, the hard fact is that the shares fell $3.55 to close at $2.39 on August 7, 2026, after the company disclosed a U.S. Department of Justice civil investigative demand in its August 6 Form 10-Q. That kind of disclosure does not merely dent confidence; it forces...

Continue Reading
Haemonetics Opens Europe for VASCADE MVP XL Device

Updated Category News Views 31

A larger collagen plug is hardly cocktail-party material, yet it can matter a great deal when it sits inside a procedure workflow hospitals are trying to speed up. Haemonetics has received CE Mark certification under the EU Medical Device Regulation for VASCADE MVP XL, its larger-bore venous vascular closure system, and first commercial European procedures were completed...

Continue Reading
Fapon’s Enzyme Push Meets Diagnostics Reality at AMP

Updated Category News Views 85

Enzymes rarely get applause at industry meetings, but they can quietly decide whether a diagnostic workflow behaves or becomes a lab headache. Fapon used its AMP 2026 appearance in Seattle to make that unglamorous case: better enzyme design may help assays move faster and keep working when samples get messy. The company wrapped up the November 10–14 meeting after...

Continue Reading
Photocure Opens a New Access Route for Hexvix Patients

Updated Category News Views 31

Forty-plus markets just moved from “not available” toward a workable route for individual bladder cancer patients, and that is the real substance of Photocure’s new arrangement with Clinigen. This is not a sweeping product launch, nor is it an approval announcement dressed up in confetti. It is a Named Patient Program, which matters because the regulatory plumbing...

Continue Reading
Kids First Data Sharing Raises Pediatric Research Bar

Updated Category News Views 68

Thirty-eight thousand children’s records are not a headline gimmick; they are a serious argument for treating research data as an asset that must keep working after the first study ends. The Gabriella Miller Kids First Data Resource Center’s ten-year review, published in the September 2026 issue of The American Journal of Human Genetics, makes that argument with...

Continue Reading
DEFSEC Tackles Nasdaq Bid Price Hurdle with Share Move

Updated Category News Views 68

Navigating Bid Price Deficiency Issues Well, it seems DEFSEC Technologies Inc. found themselves in a tricky spot last week. A nasty gram from Nasdaq’s Listing Qualifications Department pointing out that DEFSEC's shares had dipped below that $1.00 per share requirement for too long—a full 30 business days. Now, don't panic just yet. This isn't about the shares getting...

Continue Reading
WYBOT's New Robots Push Hands-Free Pool Care in Lyon

Updated Category News Views 0

A pool robot climbing out of the water to dock itself is the sort of demo that makes people stop mid-aisle at a trade show. WYBOT brought precisely that kind of attention-grabber to Piscine Global Lyon 2026, running November 17–20 at Eurexpo Lyon. The company is showing a broader lineup, but the M3 Pro is plainly the headline act: WYBOT calls it the world's first...

Continue Reading

Top 5 Most Recently Viewed Articles

Carrier Global Under Fire: An Investor's Investigation

Updated Category News Views 63

Sometimes the heat in the boardroom can match the heat of a summer's day. Enter Carrier Global Corporation (NYSE: CARR), where a group of folks who should've had their numbers kept tidy started playing with fire. Now there's an invite to a showdown from Schall, Brown & Schwartz LLP. They've thrown down the gauntlet to dig into whether Carrier’s statements could put them...

Continue Reading
Wise Group Faces Class Action Over Misleading Statements

Updated Category News Views 15

Wise Group plc: Legal Storm Brewing on the Horizon Looks like Wise Group's NASDAQ journey might be hitting some turbulence. Shareholders who picked up shares of the NASDAQ ticker WSE between May 11 and July 23, 2026, are getting a nudge to join a class action lawsuit that's gaining steam. Nothing sends a chill down a stockholder’s spine quite like the term "materially...

Continue Reading
FTI Consulting Enhances AI Capabilities with New Leadership

Updated Category News Views 151

FTI Consulting Announces New Senior Director for AI Innovation Global business advisory firm FTI Consulting, Inc. (NYSE: FCN), has recently appointed Brian Knudson as Senior Managing Director in the Data & Technology Transformation practice within the Corporate Finance & Restructuring segment. This strategic hire showcases FTI's commitment to enhancing its capabilities in...

Continue Reading
Viasat Launches Government Services via ViaSat-3 F1 Satellite

Updated Category News Views 156

Viasat Launches Government Services via ViaSat-3 F1 Satellite Viasat is now providing crucial satellite services to the U.S. Marine Corps using the ViaSat-3 network. This launch marks a significant stride towards enhancing connectivity for government operations. Connecting Military Operations The Marine Wing Communications Squadron 38 (MWCS-38) and the 3rd Marine Littoral...

Continue Reading
Automatic Trash Cans: A Game-Changer for Households

Updated Category News Views 87

Tired of Wrestling with Trash Cans? You'd think in this high-tech era, someone would've cracked the code on trash day drudgery. Well folks, the TRASH HAULER might just be the answer. Created by an inventive mind from Manhattan, Kansas, this gizmo is out to revolutionize the way we handle our garbage—by doing the heavy lifting for us on pickup day. The Idea Behind TRASH...

Continue Reading